Rochester Clinical Research is enrolling adults ages 50 to 64 for a vaccine research study focused on helping prevent C. diff infection.
If you are generally healthy and interested in participating in medical research, you may qualify.
C. diff Prevention
Age Range:
50 to 60
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This study is testing an investigational vaccine designed to help protect against Clostridioides difficile (C. diff), a bacteria that can cause severe diarrhea and intestinal illness.
Qualifications
You may qualify if you:
- Are 50 to 64 years old
- Are generally healthy
- Are not currently diagnosed with C. diff infection
Additional eligibility criteria will be reviewed by the study team.
FEATURED STUDIES
Rochester Clinical Research is currently enrolling adults for a research study evaluating a once-weekly injection for people with knee pain […]
Rochester Clinical Research is enrolling adults ages 18 and older for a study looking at a new treatment for people […]
Rochester Clinical Research is enrolling adults ages 50 to 64 for a vaccine research study focused on helping prevent C. […]
Rochester Clinical Research (RCR) is enrolling volunteers for a research study testing an investigational pneumococcal vaccine. This study is looking […]
Rochester Clinical Research in Buffalo is conducting a research study focused on Lyme disease prevention.
Rochester Clinical Research is currently enrolling adults in a new smoking cessation research study. This trial is designed to evaluate […]